Peregrine Ventures backed the bargain, which targets consolidated sales of greater than roughly $126 million by 2030.
Japan’s Kaneka obtains Israeli clinical company for $100m
Wednesday, 3 Sep 2025
Exclusive insights, data, and analysis for financial market experts.
Search
Have an existing account?
Sign In
